Rheumatologists deal mainly with immune-mediated disorders of the musculoskeletal system, soft tissues, autoimmune diseases, vasculitides, and inherited connective tissue disorders.
The application was initially implemented within various clinics and programs at the University Health Network in Canada. Designed to handle prospective clinical research and patient-reported outcomes, the DADOS Platform is developed, maintained and supported by the Electronic Data Capture Program at the Techna Institute.
The Rheumatology program at Toronto’s University Health Network has used DADOS to effectively reduce their physical data storage from a thick binder per patient to almost nothing. Within the DADOS database, homunculus results can be saved like any other encounter and any changes made within the homunculus are then recorded in the audit trail, allowing for quick trend analysis. Since its implementation, the homunculus continues to prove that a simple idea can have a great effect.
Learn about how DADOS team developed the Homonculus for the Rheumatology Division at UHN
DADOS was able to help take overwhelming amounts of precise paper notes and digitize the process.
The Consortium of Rheumatology Researchers of North America (Corrona), one of the largest real-world prospective data sets for rheumatoid arthritis (RA), has expanded to include datasets for other autoimmune diseases, including gout, inflammatory bowel disease, psoriatic arthritis/spondyloarthropathy, psoriasis, and multiple sclerosis.
Leslie R. Harrold, chief scientific officer at Corrona LLC, explained that the “goal is to gain a deeper understanding of patterns of care, effectiveness and safety outcomes in autoimmune diseases.”
Since 2011, over 430 abstracts at medical conferences and 144 manuscripts were created using data collected through Corrona. Read the full article to understand how this data is used in assessing treatment effectiveness and safety of a medication.
DADOS allows clinicians to monitor their patients’ progress and adjust their treatment plans as necessary, and can also prospectively collect data to power research initiatives.
With healthcare moving towards the value-based model, more practitioners are using patient-reported outcomes (PROs) to document their patients’ quality of life. Based on a survey by Health Catalyst only one in five hospitals in the U.S. use PROs consistently. Among the respondents who used patient-reported outcomes to some extent were those engaged in chronic disease management, surgical interventions, post-surgical patient tracking, mental healthcare, and cancer management. Read the full article to learn how providing patients with a more active role in their care decision-making can improve their health.
However, the survey also indicated that nearly three-quarters of respondents had plans to begin using PROs. DADOS can help with these objectives, offering PROs for various specialities including orthopaedics, plastic surgery, rheumatology, rehabilitation, as well as prostate and head and neck cancer. Designed with the patient in mind, DADOS guides care delivery and allows physicians to tailor treatment to the needs of each patient.
According to a study published in the Journal of Rheumatology, the Patient-Reported Outcomes Measurement Information System Global Health Short Form (PROMIS10) is an efficient screening instrument for impaired physical function, pain, and emotional distress in outpatients with systemic lupus erythematosus (SLE). Read the study abstract to learn more about PROMIS10 and how it can be evaluated in rheumatic diseases.
With a robust bank of PROMIS CAT tools, DADOS allows you to seamlessly collect valid patient-reported outcomes, focusing on relevant health status domains. Tailored to each patient, the system administers questions based on the patient’s previous answers, requiring less time for completion.
Looking to skip complicated setup procedures and start working efficiently, immediately?
Contact us to try out a demo of DADOS or ask us questions to see if your project would be a good fit.
Sound too good to be true?